CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
Original article

STAT+: Novo may be getting a better deal than expected with Medicare’s Bridge program

Positive
AI Analysis

Summary

Eli Lilly and Novo Nordisk are reportedly benefiting favorably from the Trump administration's Medicare Bridge pilot program that covers obesity drugs for seniors at $245 per month.

Importance:5/10
Sentiment:
0.60
obesity drugsMedicareBridge programpricingTrump administrationpolicy
Related Companies

Read the original article

Published by STAT News on September 22, 2026 2:23 PM

Read Original